All Comparisons/UpToDate (Wolters Kluwer) vs Bayesian Health

VNDRIQ — Vendor Comparison

UpToDate (Wolters Kluwer) vs Bayesian Health

Side-by-side comparison of BAA status, PHI exposure, AI training risk, HIPAA suitability, and VNDRIQ governance scores.

UpToDate (Wolters Kluwer)45
Bayesian Health63

UpToDate (Wolters Kluwer)

Clinical Intelligence AI

Verification pending

Bayesian Health

Clinical Intelligence AI

Verification pending

VNDRIQ Scores

45

Overall

Privacy Score52
Governance Score33
Healthcare Readiness44
AI Risk Score50

63

Overall

Privacy Score43
Governance Score85
Healthcare Readiness69
AI Risk Score55

Approval Tier

Restricted / Review Required
Approved

BAA Status

Verify Directly
Standard for enterprise healthcare agreements

PHI Exposure Risk

High

AI Training Risk

Medium

HIPAA Risk Level

Medium

Review Frequency

—

Quarterly

Recommended Use

—

Clinical decision support for early detection of sepsis and other clinical deterioration in acute care settings.

Restrictions

—

Not validated for pediatric, labor/maternity, post-surgical (within 90 minutes), or unstabilized trauma patients.

Executive Summary

UpToDate (Wolters Kluwer)

Clinical Intelligence AI

UpToDate (Wolters Kluwer) is classified as Restricted / Review Required with a BAA status of Verify Directly. PHI exposure is rated Unknown and AI training risk is Unknown.

52

Privacy

33

Governance

44

Healthcare

50

AI Risk

Bayesian Health

Clinical Intelligence AI

Bayesian Health is classified as Approved with a BAA status of Standard for enterprise healthcare agreements. PHI exposure is rated High and AI training risk is Medium. Clinical decision support for early detection of sepsis and other clinical deterioration in acute care settings.

43

Privacy

85

Governance

69

Healthcare

55

AI Risk

Recommended For

UpToDate (Wolters Kluwer)

Currently under review — not recommended for active PHI deployment

Bayesian Health

Clinical decision support for early detection of sepsis and other clinical deterioration in acute care settings.

Organizations with established governance workflows

Multi-location healthcare groups needing standardized vendor status

Governance Considerations

UpToDate (Wolters Kluwer)

BAA has not been confirmed. Execute BAA before processing PHI.

Bayesian Health

PHI exposure is elevated. Review data flow documentation.

Quarterly reviews are required — establish internal review cadence.

Restrictions noted: Not validated for pediatric, labor/maternity, post-surgical (within 90 minutes), or unstabilized trauma patients.

Questions to Ask Before Approval

01

Has the vendor executed a Business Associate Agreement (BAA) with your organization?

02

Does the vendor use customer data to train AI models? Can you opt out?

03

Where is PHI stored, processed, and transmitted?

04

What data retention and deletion policies apply to your PHI?

05

Has the vendor undergone a third-party HIPAA or SOC 2 audit?

06

What is the vendor's incident response and breach notification process?

07

Does the vendor offer audit logging for PHI access?

08

What subprocessors have access to PHI through this vendor?

Request Vendor Evaluation

Get a structured risk assessment for any vendor.

Request Benchmark Report

Compare vendors across your full stack.

Book Governance Assessment

Talk to a VNDRIQ governance specialist.